The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis
Consulting or Advisory Role - Bayer; Janssen
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst)
 
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen; Sanofi
Speakers' Bureau - Bayer; Janssen
Research Funding - Bayer
Relationship between quality of life and overall survival in metastatic castration-resistant prostate cancer (mCRPC) patients in ALSYMPCA.
 
Sten Nilsson
Consulting or Advisory Role - Bayer; Roche
 
A. Oliver Sartor
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Bristol-Myers Squibb; Celgene; Johnson & Johnson; Medivation; Oncogenex; Sanofi; Tokai Pharmaceuticals
Research Funding - Bayer (Inst); Dendreon (Inst); Endocyte (Inst); Innocrin Pharma (Inst); Johnson & Johnson (Inst); Sanofi (Inst)
 
Nicholas J. Vogelzang
Employment - US Oncology
Stock and Other Ownership Interests - Caris Life Sciences
Honoraria - Abbvie; Bavarian Nordic; Dava Oncology; Dendreon; Endocyte; Janssen Oncology; Mannkind; Pfizer; UpToDate
Consulting or Advisory Role - Amgen; AVEO; Bayer; BIND Biosciences; Cerulean Pharma; Churchill Pharmaceuticals; Genentech/Roche; HERON; Janssen Biotech; Labceutics; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Caris MPI; Dendreon; Genentech/Roche; GlaxoSmithKline; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Endocyte (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Parexel (Inst); Progenics (Inst); US Oncology (Inst); Viamet Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer/Onyx; Celgene; Dendreon; Exelixis; Genentech/Roche; Novartis; Pfizer; US Oncology
 
Robert E. Coleman
Research Funding - Bayer (Inst)
Expert Testimony - Novartis
 
Joe M. O'Sullivan
No Relationships to Disclose
 
Neal D. Shore
Consulting or Advisory Role - Bayer; Dendreon; Ferring; Janssen Scientific Affairs; Medivation/Astellas; Sanofi; Takeda; Tolmar
 
Daniel Heinrich
No Relationships to Disclose
 
David Bottomley
Consulting or Advisory Role - Bayer
Travel, Accommodations, Expenses - Bayer
 
Peter Hoskin
No Relationships to Disclose
 
Lars Franzen
No Relationships to Disclose
 
Arne Solberg
No Relationships to Disclose
 
Jonathan D. Reuning-Scherer
Consulting or Advisory Role - Bayer
 
Lin Zhan
Employment - Bayer
Travel, Accommodations, Expenses - Bayer
 
Chris Parker
Consulting or Advisory Role - Bayer
Speakers' Bureau - Janssen
Research Funding - Bayer (Inst)